We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$16.8B
AUM Growth
+$2.43B
(+17%)
Cap. Flow
+$2.2B
Cap. Flow
% of AUM
13.07%
Top 10 Holdings %
Top 10 Hldgs %
12.03%
Holding
1,764
New
564
Increased
341
Reduced
326
Closed
526
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.58% |
| 3 | Consumer Staples | 7.89% |
| 4 | Financials | 7.87% |
| 5 | Healthcare | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TESO
326
DELISTED
Tesco Corp
TESO
| $13.2M | 0.08% |
1,529,397
+186,920
| +14% | +$1.32M |
|
327
CALL
iShares MSCI Brazil ETF
EWZ
$8.95B
| $13.2M | 0.08% |
500,000
+415,000
| +488% | +$8.92M |
|
328
CALL
Cboe Global Markets
CBOE
$29.9B
| $13.1M | 0.08% |
+200,000
| New | +$12.8M |
|
329
Wynn Resorts
WYNN
$10.6B
| $13M | 0.08% |
139,578
+79,578
| +133% | +$5.87M |
|
|
FL
330
DELISTED
Foot Locker
FL
| $13M | 0.08% |
201,950
-7,381
| -4% | -$479K |
|
331
GSK
GSK
$106B
| $12.9M | 0.08% |
+254,844
| New | +$12.7M |
|
|
X
332
CALL
DELISTED
US Steel
X
| $12.8M | 0.08% |
+800,000
| New | +$7.97M |
|
|
MJN
333
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
| $12.7M | 0.08% |
150,000
+50,000
| +50% | +$3.72M |
|
334
PUT
Dillards
DDS
$9.56B
| $12.7M | 0.08% |
+150,000
| New | +$11.2M |
|
335
Arthur J. Gallagher & Co
AJG
$63.6B
| $12.7M | 0.08% |
+285,804
| New | +$11.4M |
|
336
Comcast
CMCSA
$90B
| $12.7M | 0.08% |
415,974
-1,626,636
| -80% | -$46.7M |
|
337
Sally Beauty Holdings
SBH
$1.58B
| $12.7M | 0.08% |
390,727
+126,157
| +48% | +$3.74M |
|
338
Vipshop
VIPS
$7.53B
| $12.6M | 0.08% |
+981,893
| New | +$12.3M |
|
339
Southern Company
SO
$107B
| $12.6M | 0.08% |
+244,221
| New | +$11.9M |
|
340
Vishay Intertechnology
VSH
$5.43B
| $12.6M | 0.07% |
1,033,426
-1,792,486
| -63% | -$20.6M |
|
341
Valley National Bancorp
VLY
$8.04B
| $12.6M | 0.07% |
+1,320,774
| New | +$12M |
|
|
ALXN
342
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.5M | 0.07% |
89,886
+45,948
| +105% | +$6.75M |
|
|
TMH
343
DELISTED
Team Health Holdings Inc
TMH
| $12.4M | 0.07% |
297,543
+284,493
| +2,180% | +$11.6M |
|
344
Hancock Whitney
HWC
$6.24B
| $12.4M | 0.07% |
539,929
+493,116
| +1,053% | +$11.6M |
|
345
Bausch Health
BHC
$2.34B
| $12.4M | 0.07% |
469,700
+348,650
| +288% | +$25.8M |
|
346
CALL
Edwards Lifesciences
EW
$51.7B
| $12.3M | 0.07% |
420,000
+60,000
| +17% | +$1.66M |
|
347
Box
BOX
$4.6B
| $12.3M | 0.07% |
1,000,000
+922,331
| +1,188% | +$10.5M |
|
348
Shake Shack
SHAK
$2.87B
| $12.2M | 0.07% |
+327,440
| New | +$11.8M |
|
|
GNRT
349
DELISTED
Gener8 Maritime, Inc.
GNRT
| $12.2M | 0.07% |
1,729,975
+650,000
| +60% | +$4.2M |
|
|
JAH
350
DELISTED
JARDEN CORPORATION
JAH
| $12.1M | 0.07% |
205,805
-232,192
| -53% | -$12.4M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Balyasny Asset Management held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Balyasny Asset Management deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Balyasny Asset Management's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Balyasny Asset Management added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Balyasny Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Balyasny Asset Management fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Balyasny Asset Management's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Balyasny Asset Management opened 564 new positions and closed 526 in Q1 2016.
- Balyasny Asset Management's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.